LNP Strategy

Building Better RNA Medicines Through Smarter LNP Formulation Strategy

Aula Al Muslim, Ph.D.

Recipharm Advanced Bio

Roundtable

How is the increasing complexity of modalities reshaping CDMO differentiation and specialization strategies?

Pharma's Almanac

GCE

Rewriting the Genetic Code: Designing Biologics with Noncanonical Amino Acids

David Alvaro, Ph.D.; April Stanley, MS MBA

Pharma's Almanac

Neuro RNA

Targeting RNA in the Nervous System: The Rise of Antisense and RNA Therapeutics

David Alvaro, Ph.D.

Pharma's Almanac

mRNA Vaccine

When Review Stops at the Door: The FDA, mRNA Influenza Vaccines, and the Future of Regulatory Consistency

David Alvaro, Ph.D.; April Stanley, MS MBA

Pharma's Almanac

RNA Polymerase

Smarter Polymerases, Cleaner Transcripts, Better RNA

Jing Zhu, Ph.D.

Recipharm Advanced Bio

CRISPR

Integrated Capabilities Enable Faster Development of Effective CRISPR Therapies

Jessica Madigan; Amanda Haas

BIOVECTRA

LNPs

Expanding LNP Applications Beyond mRNA Vaccines

Jan Bekker; Phillip Elliott, Ph.D.; Jason Arcediano

BioCina

mRNA Therapeutics

mRNA Therapeutics Are Just Getting Started: Charting a Post-Pandemic Path Forward

Jan Bekker; Phillip Elliott, Ph.D.; Jason Arcediano

BioCina

Biological Design

Foundational Models in Biological Design, Part 3: Translational and Regulatory Outlook

David Alvaro, Ph.D.

Pharma's Almanac

Biological Design

Foundational Models in Biological Design, Part 2: Designing for Manufacturability

David Alvaro, Ph.D.

Pharma's Almanac

Biological Design

Foundational Models in Biological Design, Part 1: Multimodal and Controllable

David Alvaro, Ph.D.

Pharma's Almanac

mRNA–LNP

Integrated mRNA–LNP Manufacturing as a Platform for Innovation

Jan Bekker

BioCina

Biotechs

Next-Gen Biopharma: The Startups Leading the Charge

Cynthia A. Challener, Ph.D.

Pharma's Almanac

mRNA Vaccines

Ideology Over Evidence: RFK Jr. Just Set Vaccine Science Back a Decade

David Alvaro, Ph.D.

Pharma's Almanac

Continuous

Novel Integration of Process Analytical Technologies for Continuous Biomanufacturing

Edita Botonjic-Sehic, Ph.D.

Recipharm Advanced Bio

Oral RNA

Unlocking Oral RNA Therapeutics: Overcoming Barriers to Gut-Stable Delivery

David Alvaro, Ph.D.

Pharma's Almanac

Nanoparticles

How DIANT Pharma is Transforming Nanoparticle Manufacturing

Antonio Costa, Ph.D.

DIANT Pharma

RNA Editing

Rewriting the Script: The Past, Present, and Future of RNA Editing Therapeutics

David Alvaro, Ph.D.

Pharma's Almanac